Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Pinduoduo
PDD
$126B
| $3.88M | ﹤0.01% |
50,925
+43,716
| +606% | +$4.04M |
|
|
TLN
1427
PUT
Talen Energy Corp
TLN
$15.1B
| $3.88M | ﹤0.01% |
10,100
+4,600
| +84% | +$1.69M |
|
1428
CALL
Genmab
GMAB
$20.6B
| $3.88M | ﹤0.01% |
+141,100
| New | +$3.75M |
|
1429
LKQ Corp
LKQ
$6.52B
| $3.88M | ﹤0.01% |
147,188
+104,450
| +244% | +$2.9M |
|
1430
CALL
ARK Innovation ETF
ARKK
$6.72B
| $3.87M | ﹤0.01% |
+47,900
| New | +$3.66M |
|
1431
CALL
Cogent Biosciences
COGT
$6.37B
| $3.87M | ﹤0.01% |
+100,000
| New | +$3.5M |
|
1432
Fortuna Silver Mines
FSM
$3.57B
| $3.86M | ﹤0.01% |
456,837
-109,926
| -19% | -$1.07M |
|
1433
CALL
Hims & Hers Health
HIMS
$7.88B
| $3.85M | ﹤0.01% |
111,000
-12,600
| -10% | -$338K |
|
1434
Rocket Companies
RKT
$39.4B
| $3.84M | ﹤0.01% |
243,830
-2,562,273
| -91% | -$36.9M |
|
1435
Elevance Health
ELV
$86.9B
| $3.84M | ﹤0.01% |
9,927
-255,733
| -96% | -$94.8M |
|
1436
CALL
Amgen
AMGN
$238B
| $3.84M | ﹤0.01% |
10,600
-900
| -8% | -$308K |
|
1437
Workiva
WK
$4.07B
| $3.83M | ﹤0.01% |
78,981
+58,042
| +277% | +$2.99M |
|
1438
Adtran
ADTN
$633M
| $3.83M | ﹤0.01% |
+275,489
| New | +$4.3M |
|
|
ETHA
1439
CALL
iShares Ethereum Trust ETF
ETHA
$7.26B
| $3.83M | ﹤0.01% |
+322,000
| New | +$5M |
|
1440
PUT
D.R. Horton
DHI
$41.5B
| $3.83M | ﹤0.01% |
+23,500
| New | +$3.51M |
|
1441
Northern Oil and Gas
NOG
$2.91B
| $3.82M | ﹤0.01% |
210,592
-61,596
| -23% | -$1.46M |
|
1442
OR Royalties Inc
OR
$6.76B
| $3.81M | ﹤0.01% |
120,488
+104,097
| +635% | +$3.84M |
|
1443
Hess Midstream
HESM
$5.02B
| $3.81M | ﹤0.01% |
101,258
+95,166
| +1,562% | +$3.66M |
|
1444
Prudential
PUK
$35B
| $3.78M | ﹤0.01% |
141,126
+108,970
| +339% | +$3.18M |
|
1445
PUT
MP Materials
MP
$10.7B
| $3.77M | ﹤0.01% |
+67,300
| New | +$4.1M |
|
1446
Ferrovial N.V. Ordinary Shares
FER
$45.3B
| $3.76M | ﹤0.01% |
+54,747
| New | +$3.74M |
|
1447
Strategy Inc
MSTR
$47.4B
| $3.75M | ﹤0.01% |
43,092
+20,277
| +89% | +$2.94M |
|
1448
RadNet
RDNT
$6.05B
| $3.74M | ﹤0.01% |
60,683
+26,437
| +77% | +$1.49M |
|
|
CRCL
1449
PUT
Circle Internet Group
CRCL
$22.3B
| $3.74M | ﹤0.01% |
59,700
+26,100
| +78% | +$2.54M |
|
1450
CALL
iShares MSCI Japan ETF
EWJ
$22.4B
| $3.73M | ﹤0.01% |
+40,000
| New | +$3.63M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.